龍蟠科技(603906.SH):擬收購貝特瑞並表範圍內的磷酸鐵鋰相關資產和業務
格隆匯 12 月 25日丨龍蟠科技(603906.SH)公佈,2020年12月25日,公司與貝特瑞新材料集團股份有限公司(“貝特瑞”)共同簽署《關於收購貝特瑞新材料集團股份有限公司名下磷酸鐵鋰相關資產和業務之框架協議》,龍蟠科技擬通過自身或其下屬公司收購貝特瑞合併報表範圍內的磷酸鐵鋰相關資產和業務(“標的資產和業務”),貝特瑞同意龍蟠科技收購上述標的資產和業務。
根據《框架協議》約定,龍蟠科技在《框架協議》簽署之日起7個工作日內應向貝特瑞支付3000萬元的誠意金,若龍蟠科技逾期支付誠意金達到5個工作日的,《框架協議》自動終止。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.